National Health Investors, Inc. (NHI)Rep. Gilbert Cisneros (CA31) disclosed a purchase $1K–$15K
Rep. Gilbert Cisneros (CA31) disclosed a purchase of National Health Investors, Inc. in the $1K–$15K range.
- $1,001–$15,000
- Reported range · official band, not an exact amount
- 29 days
- Disclosure lag
- Traded
- Jan 15, 2026
- Disclosed
- Feb 13, 2026
The story around this disclosure
Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.
- Dec 15, 2025Company filing · Form 8-K · Executive changeChanged a top executive or board member“On December 15, 2025, National Health Investors, Inc. (the “Company”) entered into a Change in Control Severance Agreement (a “CIC Severance Agreement”) with each of the following named executive officers of the Company: D. Eric Mendelsohn, Kristin S. Gaines, Kevin C. Pascoe, John L. Spaid and David L. Travis (each, an “Executive”).”
- Jan 15, 2026 · this disclosureCongressDisclosed purchase of NHI — reported range $1,001 - $15,000
What came next
- Feb 17, 2026Company filing · Form 8-K · Executive changeChanged a top executive or board member“On February 17, 2026, the Board of Directors (the “Board”) of National Health Investors, Inc. (the “Company”), upon the recommendation of its Nominating and Corporate Governance Committee, increased the size of the Board and appointed Lilly H. Donohue to fill the vacant seat, effective immediately, with an initial term expiring at the 2026 annual meeting of stockholders (the “2026 Annual Meeting”).”
- Feb 26, 2026Company filing · Form 8-K · ResultsReported its results
- Apr 20, 2026Company filing · Form 8-K · Material agreement, Agreement endedSigned an important agreement, and ended an important agreement (and 1 more item)
- Apr 20, 2026Company filing · Form 8-K · Material agreement, Agreement endedSigned an important agreement, and ended an important agreement (and 1 more item)
- Apr 20, 2026Company filing · Form 8-K · Executive changeChanged a top executive or board member“On April 21, 2026, John L. Spaid notified the Board of Directors (the “Board”) of National Health Investors, Inc. (the “Company”) of his intention to retire from his position as Executive Vice President of Finance, Chief Financial Officer and Treasurer, effective as of July 1, 2026.”
- May 4, 2026Company filing · Form 8-K · ResultsReported its results
How to read House Clerk periodic transaction report
The STOCK Act is a 2012 US law that requires members of Congress, and some senior staff, to publicly report their stock trades, and those of their spouse and dependent children, within 45 days.
Full guide: What is the STOCK Act?
What else is on file for National Health Investors, Inc.
For National Health Investors, Inc., OQRO holds 1 Congress trade report and 1 fund holdings report (13F) dated in the last 90 days.
These are records OQRO holds, counted by their date, not a measure of how much trading took place. Routine paperwork such as option exercises and tax withholding is left out. Everything for the company is on its NHI page.
Other recent filings by Rep. Gilbert Cisneros (CA31)
- House Clerk periodic transaction report at Globus Medical (GMED)Sep 10, 2026
- House Clerk periodic transaction report at Horace Mann Educators Corporation (HMN)Sep 10, 2026
- House Clerk periodic transaction report at Insulet Corporation (PODD)Sep 10, 2026
- House Clerk periodic transaction report at NXP Semiconductors (NXPI)Sep 10, 2026
- House Clerk periodic transaction report at Tesla (TSLA)Sep 10, 2026
The full history of Rep. Gilbert Cisneros (CA31) is on the profile page.
How this filing works
Other disclosures at National Health Investors, Inc.
- House Clerk periodic transaction reportSep 4, 2026
- SEC Form 13F-HRAug 7, 2026
- SEC Form 13F-HRMay 8, 2026
- SEC Form 13F-HRFeb 12, 2026
- SEC Form 13F-HRNov 12, 2025
- SEC Form 13F-HRAug 12, 2025
Everything OQRO holds on this company is on its NHI page.
This is one filing. OQRO holds the rest
Insider trades filed with the SEC, stock trades disclosed by members of Congress, fund holdings from 13F filings and federal contract awards, each one in plain words next to its official filing. On this page it opens why the trade stands out, what the company did around that time, the price since, and every field of the form.
OQRO Pro is a paid subscription. You see the price before you pay
OQRO describes public disclosures and context calculated from them. It does not give personalized advice and does not recommend any transaction. How OQRO treats data